Clinical Trials Directory

Trials / Sponsors / Anders Fink-Jensen, MD, DMSci

Anders Fink-Jensen, MD, DMSci

Academic / Other · 11 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEffect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
Cannabis Use Disorder, Cannabis Use Disorders, Cannabis Abuse
Phase 22026-04-30
RecruitingInvolvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder
Alcohol Use Disorder
N/A2025-05-07
RecruitingEffects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Alcohol Use Disorder, Alcohol Abuse/Dependence, Alcohol Dependence
Phase 22025-05-05
CompletedPsilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Alcohol Use Disorder
Phase 22023-09-01
Active Not RecruitingPsilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Alcohol Use Disorder (AUD)
Phase 22023-02-09
Active Not RecruitingDoes GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antips
Metabolic Disturbance, Schizophrenia, Type 2 Diabetes
Phase 42021-09-01
CompletedIs Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
Mental Disorder, Metabolic Disturbance, Feasibility
Phase 42021-07-01
TerminatedCOVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region
Covid19, Severe Mental Disorder
—2021-01-18
UnknownDoes a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans?
Alcohol Use Disorder, Alcohol Withdrawal, Ketosis
N/A2020-06-15
CompletedDoes Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
Alcohol Dependence, in Remission, Addiction, Alcohol
Phase 22017-08-07
CompletedThe Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
Schizophrenia
Phase 42015-09-01